This is an ongoing clinical trial in which pediatric and adult patients with PHTS with or without NDD are followed throughout their lifespan for other manifestations with age-related penetrance, such as cancer (Natural History Study of Individuals with Autism and Germline Heterozygous PTEN Mutations23). This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.